Clearside Biomedical Inc (CLSD)- common stock at a price ot public of $13.00, current price as of today closed at $10.38, for ~ -21% discount. Positive PEACHTREE pivotal Phase 3 trial of suprachoroidal in March 2018. http://ir.clearsidebio.com/news-releases/news-release-details/clearside-biomedical-announces-positive-topline-results-pivotal
Chart found support.
Just a idea. Best of luck.
Update: CLSD up +9.70% on double volume, typically, this call for follow up second-day run. Best of luck.